share_log

8-K: Current report

8-K: Current report

8-K:重大事件
美股SEC公告 ·  07/02 19:34
牛牛AI助理已提取核心訊息
On June 28, 2024, SeaStar Medical Holding Corporation entered into a warrant redemption agreement with an institutional investor to redeem all 126,330 warrants for purchasing the company's common stock. The warrants were initially issued as part of a securities purchase agreement on March 15, 2023. SeaStar Medical will pay a total of $449,734.80 for the redemption, with $100,000 paid on July 1, 2024, and the remaining $349,734.80 due by August 27, 2024, accruing interest at 7% per annum. This redemption satisfies all obligations under the original purchase agreement and associated notes, with no further obligations or rights remaining except those that survive the termination of the agreements.
On June 28, 2024, SeaStar Medical Holding Corporation entered into a warrant redemption agreement with an institutional investor to redeem all 126,330 warrants for purchasing the company's common stock. The warrants were initially issued as part of a securities purchase agreement on March 15, 2023. SeaStar Medical will pay a total of $449,734.80 for the redemption, with $100,000 paid on July 1, 2024, and the remaining $349,734.80 due by August 27, 2024, accruing interest at 7% per annum. This redemption satisfies all obligations under the original purchase agreement and associated notes, with no further obligations or rights remaining except those that survive the termination of the agreements.
2024年6月28日,SeaStar醫療控股公司與一家機構投資者簽署了一份認股權贖回協議,以贖回所有126,330個購買公司普通股的認股權。這些認股權最初是作爲2023年3月15日證券購買協議的一部分發行的。SeaStar醫療將支付總額爲449,734.80美元的贖回款項,其中100,000美元將於2024年7月1日支付,其餘的349,734.80美元需在2024年8月27日之前支付,以7%的年息計息。此次贖回滿足了原始購買協議和相關注記的所有義務,除了終止協議後仍保留的義務或權利外,不再存在任何其他義務或權利。
2024年6月28日,SeaStar醫療控股公司與一家機構投資者簽署了一份認股權贖回協議,以贖回所有126,330個購買公司普通股的認股權。這些認股權最初是作爲2023年3月15日證券購買協議的一部分發行的。SeaStar醫療將支付總額爲449,734.80美元的贖回款項,其中100,000美元將於2024年7月1日支付,其餘的349,734.80美元需在2024年8月27日之前支付,以7%的年息計息。此次贖回滿足了原始購買協議和相關注記的所有義務,除了終止協議後仍保留的義務或權利外,不再存在任何其他義務或權利。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。